We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to RHO

INS — RHO

Text-mined interactions from Literome

Begum et al., Mol Endocrinol 2000 (Diabetes Mellitus, Type 2...) : The decrease observed in MBS phosphorylation was due to insulin induced inhibition of Rho kinase activity ... Insulin also prevented a thrombin mediated increase in Rho kinase activation and abolished the thrombin induced increase in MBS phosphorylation and MBP inactivation
Sandu et al., Diabetes 2000 (Diabetes Mellitus, Type 2) : VSMCs isolated from Goto-Kakizaki ( GK ) diabetic rats ( a model for type 2 diabetes ) exhibited marked impairment in MBP activation by insulin that was accompanied by failure of insulin to decrease the phosphorylation of a regulatory myosin bound subunit (MBS) of MBP and inhibit Rho kinase activity resulting in increased myosin light-chain (MLC)20 phosphorylation and VSMC contraction
Sandu et al., J Appl Physiol 2001 (Hypertension) : Collectively, these results indicate that insulin inhibits Rho signaling by decreasing RhoA translocation via the NO/cGMP signaling pathway to cause MBP activation via site-specific dephosphorylation of its regulatory subunit MBS
Kowluru et al., Diabetes 2005 (Insulinoma) : Rho guanosine diphosphate-dissociation inhibitor plays a negative modulatory role in glucose stimulated insulin secretion
Nakamura et al., Biochem Biophys Res Commun 2006 (Diabetes Mellitus) : Northern blot analysis showed that insulin mRNA levels were markedly increased by Rho-kinase inhibitors, Y-27632 and fasudil, in beta-cell derived HIT-T15 cells ... These results imply that Rho/Rho-kinase activation is involved in the suppression of insulin expression found in diabetes and that suppression of the Rho/Rho-kinase pathway could be a useful tool to augment insulin gene transcription
Petersen et al., Mol Cell Biol 2008 : Suppression of Rho-kinase impaired proadipogenic insulin/insulin-like growth factor 1 signaling, which was restored by activation of Epac
Standaert et al., Endocrinology 1996 : Insulin stimulates phospholipase D-dependent phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes
Karnam et al., J Biol Chem 1997 : Our findings suggest that : ( a ) insulin translocates Rho by a PI 3-kinase dependent mechanism, but another factor is responsible for GTP loading of Rho ; ( b ) both Rho and ARF may contribute to PC-PLD activation during insulin action ; and ( c ) Rho may be required for insulin stimulation of glucose transport
Standaert et al., J Biol Chem 1998 : Comparative effects of GTPgammaS and insulin on the activation of Rho , phosphatidylinositol 3-kinase, and protein kinase N in rat adipocytes ... Our findings suggest that ( a ) GTPgammaS and insulin activate Rho , PI 3-kinase, and PKN, albeit by different mechanisms ; ( b ) each of these signaling substances appears to be required for, and may contribute to, increases in glucose transport ; and ( c ) PKC-zeta may contribute to increases in glucose transport during insulin, but not GTPgammaS, action